Phase 3 Readout
PTCT: Phase 3 Topline: A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
June 30, 2026 · ptc923. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- PTC THERAPEUTICS, INC. (PTCT)
- Drug
- ptc923
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
- Drug
- ptc923
- Indication
- Phenylketonuria